Back to Authors

Shih, Yu‐Huan

Mayo Clinic

Department of Biochemistry and Molecular Biology

Citations 3

Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy
Long, Pamela A., Theis, Jeanne L. , Shih, Yu‐Huan, Maleszewski, Joseph J. , Aleff, Patrice C. Abell, Evans, Jared M., Olson, Timothy M. , Xu, Xiaolei , Theis, Jeanne L , Olson, Timothy M

Human Molecular Genetics | April 28, 2017 | Volume: 26 | Issue: 15 | Pages: 2874-2881

10.1093/hmg/ddx169 Get It

A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene
Long, Pamela A., Shih, Yu‐Huan, Ma, Xiao , Sundsbak, Rhianna S., Chen, Jianhua , Jiang, Yiwen , Zhao, Liqun , Hu, Xinyang , Shi, Yongyong , Ackerman, Michael J. , Ekker, Stephen C. , Redfield, Margaret M. , Ding, Yonghe , Olson, Timothy M. , Bos, J. Martijn , Wang, Jianan , Lin, Xueying , Xu, Xiaolei , Ekker, Stephen C

JCI Insight | September 7, 2016 | Volume: 1 | Issue: 14 | Pages: No page available

10.1172/jci.insight.88797 Get It

Mutagenesis screening is a powerful forward genetic approach that has been successfully applied in lower-model organisms to discover genetic factors for biological processes. This phenotype-based approach has yet to be established in vertebrates for probing major human diseases, largely because of the complexity of colony management. Herein, we report a rapid strategy for identifying genetic modifiers of cardiomyopathy (CM). Based on the application of doxorubicin stress to zebrafish insertional cardiac (ZIC) mutants, we identified 4 candidate CM-modifying genes, of which 3 have been linked previously to CM. The long isoform of DnaJ (Hsp40) homolog, subfamily B, member 6b ( dnajb6b(L) ) was identified as a CM susceptibility gene, supported by identification of rare variants in its human ortholog DNAJB6 from CM patients. Mechanistic studies indicated that the deleterious, loss-of-function modifying effects of dnajb6b(L) can be ameliorated by inhibition of ER stress. In contrast, overexpression of dnajb6(L) exerts cardioprotective effects on both fish and mouse CM models. Together, our findings establish a mutagenesis screening strategy that is scalable for systematic identification of genetic modifiers of CM, feasible to suggest therapeutic targets, and expandable to other major human diseases.
Cardiac Transcriptome and Dilated Cardiomyopathy Genes in Zebrafish
Shih, Yu‐Huan, Zhang, Yuji , Roß, Christian , Olson, Timothy M. , Ding, Yonghe , Ross, Christian A, Li, Hu , Xu, Xiaolei , Olson, Timothy M

Circulation: Cardiovascular Genetics | January 13, 2015 | Volume: 8 | Issue: 2 | Pages: 261-269

10.1161/circgenetics.114.000702 Get It

Background— Genetic studies of cardiomyopathy and heart failure have limited throughput in mammalian models. Adult zebrafish have been recently pursued as a vertebrate model with higher throughput, but genetic conservation must be tested. Methods and Results— We conducted transcriptome analysis of zebrafish heart and searched for fish homologues of 51 known human dilated cardiomyopathy–associated genes. We also identified genes with high cardiac expression and genes with differential expression between embryonic and adult stages. Among tested genes, 30 had a single zebrafish orthologue, 14 had 2 homologues, and 5 had ≥3 homologues. By analyzing the expression data on the basis of cardiac abundance and enrichment hypotheses, we identified a single zebrafish gene for 14 of 19 multiple-homologue genes and 2 zebrafish homologues of high priority for ACTC1 . Of note, our data suggested vmhc and vmhcl as functional zebrafish orthologues for human genes MYH6 and MYH7 , respectively, which are established molecular markers for cardiac remodeling. Conclusions— Most known genes for human dilated cardiomyopathy have a corresponding zebrafish orthologue, which supports the use of zebrafish as a conserved vertebrate model. Definition of the cardiac transcriptome and fetal gene program will facilitate systems biology studies of dilated cardiomyopathy in zebrafish.